Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats

Biochemical Genetics

Volumn 50, Issue 11-12, 2012, Pages 922-935

  Barakat, Ghinwa M ^a   Moustafa, Mohamed E ^a,b   Bikhazi, Anwar B ^c  

^a BEIRUT ARAB UNIVERSITY   (Lebanon)

^b Alexandria University Faculty Of Science   (Egypt)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Antidiabetic; Diabetes mellitus; Exendin 4; GLP 1 receptor; Glutathione peroxidase 1

Indexed keywords

BOVINE INSULIN; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; RAF PROTEIN; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIVER; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIVER; MALE; MAP KINASE KINASE KINASES; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; RNA, MESSENGER; SELENIUM; SODIUM SELENITE; STREPTOZOCIN; TIME FACTORS; VENOMS;

RATTUS;

EID: 84871229527     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-012-9532-2     Document Type: Article

References (43)

1. Akbaraly TN, Arnaud J, Rayman MP, Hininger-Favier I, Roussel A, Berr C, Fontbonne A (2010) Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective epidemiology of vascular ageing study. Nutr Metab (Lond) 7(21):1-7.
2. Algotar AM, Stratton MS, Xu MJ, Dalkin BL, Nagle RB, Hsu CH, Ahmann FR, Clark LC, Stratton SP (2011) Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer. Nutr Cancer 63(1):1-5.
3. Ban K, Noyan-Ashraf H, Hoefer J, Steffen-Sebastian B, Drucker DJ, Mansoor H (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagonlike peptide 1 receptor-dependent and -independent pathways. Circulation 117(18):2340-2350. (Pubitemid 351653542)
4. Bergmann U, Funatomi H, Kornmann M, Beger HG, Korc M (1996) Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun 220(3):886-890. (Pubitemid 26198607)
5. Bjorkhem-Bergman L, Torndal UB, Eken S, Nystrom C, Capitanio A, Larsen EH, Bjornstedt M, Eriksson LC (2005) Selenium prevents tumor development in a rat model for chemical carcinogenesis. Carcino 26(1):125-131. (Pubitemid 40207707)
6. Bleys J, Navas-Acien A, Guallar E (2007) Serum selenium and diabetes in US adults. Diabetes Care 30(4):829-834.
7. Campbell SC, Aldibbiat A, Marriotta CE, Landya C, Tomader A, Ferrisc WF, Butlerd CS, Shawb JA, Macfarlanea WM (2008) Selenium stimulates pancreatic b-cell gene expression and enhances islet function. FEBS Lett 582(15):2333-2337.
8. Douillet C, Tabib A, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M (1999) Selenium in diabetes: effects of selenium on nephropathy in type I streptozotocin-induced diabetic rats. J Trace Elem Exp Med 12:379-392. (Pubitemid 30234998)
9. Drucker DJ (2003) Glucagon-like peptide-1 and the islet b-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5148. (Pubitemid 37476039)
10. Drucker DJ (2007) The role of gut hormones in glucose homeostasis. J Clin Invest 117(1):24-32. (Pubitemid 46048446)
11. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V (1993) Glucagon-like peptide- 1(7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24 h secretion patterns. J Endocrinol 138:159-166. (Pubitemid 23266831)
12. Fehmann HC, Goke R, Goke B (1992) Glucagon-like peptide-1(7-37)/(7-36) amide is a new incertin. Mol Cell Endocrinol 85(1-2):C39-C44.
13. Fürnsinn C, Englisch R, Ebner K, Nowotny P, Vogl C, Waldhäusl W (1996) Insulin-like vs. non-insulinlike stimulation of glucose metabolism by vanadium, tungsten, and selenium compounds in rat muscle. Life Sci 23:1989-2000. (Pubitemid 26390200)
14. Ghosh R, Mukherjee B, Chatterjee M (1994) A novel effect of selenium on streptozotocin-induced diabetic mice. Diabetes Res 25(4):165-171.
15. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)- amide receptor of insulin-secreting b-cells. J Biol Chem 268(26):19650-19655. (Pubitemid 23270754)
16. Grankvist K, Marklund SL, Täljedal IB (1981) Cu, Zn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 199:393-398. (Pubitemid 12216744)
17. Hara K, Yonezawa K, Sakaue J, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR (1994) 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci 91:7415-7419.
18. Harmon JS, Bogdani M, Parazzoli SD, Mak SS, Oseid EA, Berghmans M, Leboeuf RC, Robertson RP (2009) Beta-cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology 150:4855-4862.
19. Hei YJ, Farahbakhshian S, Chen X, Battell ML, McNeill JH (1998) Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Mol Cell Biochem 178(1-2):367-375. (Pubitemid 28121781)
20. Hong G, Xinjun W, Zhiguo Z, Yisheng Y, Jun Y, Xiaoying L, Guang N (2007) GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine 32(1):90-95.
21. Iizuka Y, Sakurai E, Maeda K, Hikichi N (1993) Effects of selenium on the glycolysis and gluconeogenesis system in rat liver. Yakugaku Zasshi 113(7):525-531. (Pubitemid 23273312)
22. Kljai K, Runje R (2001) Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res 83:223-229. (Pubitemid 34017065)
23. Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb S (1994) Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94(3):1141-1146. (Pubitemid 24286456)
24. Labunskyy VM, Lee BC, Handy DE, Loscalzo J, Hatfield DL, Gladyshev VN (2011) Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid Redox Signal 14:2327-2336.
25. Lei XG, Cheng WH (2005) New roles for an old selenoenzyme: evidence from glutathione peroxidase-1 null and overexpressing mice. J Nutr 135:2295-2298. (Pubitemid 41429580)
26. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 301:39-51.
27. Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S (2000) Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 49:1123-1130. (Pubitemid 30439085)
28. Maiese K, Morhan SD, Chong ZZ (2007) Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 4(1):63-71. (Pubitemid 46280293)
29. McClung JP, Roneker CA, Mu W, Lisk DJ, Langlas P, Lu F, Lei XG (2004) Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. PNAS 101:8852-8857. (Pubitemid 38781575)
30. McNeill JH, Delgatty HL, Battell ML (1991) Insulinlike effects of sodium selenate in streptozocininduced diabetic rats. Diabetes 40(12):1675-1678.
31. Moriscot C, Richard M, Favrot MC, Benhamou PY (2003) Protection of insulin-secreting INS-1 cells against oxidative stress through adenoviral-mediated glutathione peroxidase overexpression. Diabetes Metab 29:145-151. (Pubitemid 36576093)
32. Mukherjee B, Anbazhagan S, Roy A, Ghosh R, Chatterjee M (1998) Novel implications of the potential role of selenium on antioxidant status in streptozotocin-induced diabetic mice. Biomed Pharmacother 52(2):89-95. (Pubitemid 28172694)
33. Mysore TB, Shinkel TA, Collins J, Salvaris EJ, Fisicaro N, Murray-Segal LJ, Johnson LE, Lepore DA, Walters SN, Stokes R, Chandra AP, O'Connell PJ, d'Apice AJ, Cowan PJ (2005) Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function. Diabetes 54:2109-2116. (Pubitemid 40911274)
34. Navarro-Alarcon M, Lopez G, Perez-Valero V, Lopez-Martinez C (1999) Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ 228:79-85. (Pubitemid 29179532)
35. Rajpathak S, Rimm E, Morris JS, Hu F (2005) Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 24:250-256.
36. Rasekh HR, Potmis RA, Nonavinakere VK, Early JL, Iszard MB (1991) Effect of selenium on plasma glucose of rats: role of insulin and glucocorticoids. Toxicol Lett 58(2):199-207.
37. Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43(11):1326-1333.
38. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15(12):2099-2111. (Pubitemid 32927927)
39. Stapleton SR (2000) Selenium: an insulin-mimetic. Cell Mol Life Sci 57(13-14):1874-1879. (Pubitemid 32102583)
40. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, Cappuccio FP, Ceriello A, Reid ME (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 47(4):217-223. (Pubitemid 351664577)
41. Trumper A, Trumper K, Horsch D (2002) Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in β (INS-1)-cells. J Endocrinol 174:233-246. (Pubitemid 34965762)
42. Wang XD, Vatamaniuk MZ, Wang SK, Roneker CA, Simmons RA, Lei XG (2008) Molecular mechanisms for hyperinsulinemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia 51:1515-1524.
43. Xu G, Kaneto H, Laybutt DR, Duvivier-Kali VF, Trivedi N, Suzuma K, King GL, Weir GC, Bonner-Weir S (2007) Down regulation of GLP-1 and GIP receptor expression by hyperglycemia. Diabetes 56:1551-1558.